GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (NAS:CTSO) » Definitions » E10

CytoSorbents (CytoSorbents) E10 : $-0.66 (As of Mar. 2024)


View and export this data going back to 2005. Start your Free Trial

What is CytoSorbents E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

CytoSorbents's adjusted earnings per share data for the three months ended in Mar. 2024 was $-0.120. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.66 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 2.90% per year. During the past 5 years, the average E10 Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of CytoSorbents was 39.80% per year. The lowest was 2.90% per year. And the median was 16.25% per year.

As of today (2024-06-08), CytoSorbents's current stock price is $0.888. CytoSorbents's E10 for the quarter that ended in Mar. 2024 was $-0.66. CytoSorbents's Shiller PE Ratio of today is .


CytoSorbents E10 Historical Data

The historical data trend for CytoSorbents's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents E10 Chart

CytoSorbents Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.84 -0.72 -0.70 -0.71 -0.66

CytoSorbents Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.70 -0.69 -0.69 -0.66 -0.66

Competitive Comparison of CytoSorbents's E10

For the Medical Devices subindustry, CytoSorbents's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CytoSorbents's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CytoSorbents's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where CytoSorbents's Shiller PE Ratio falls into.



CytoSorbents E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, CytoSorbents's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.12/131.7762*131.7762
=-0.120

Current CPI (Mar. 2024) = 131.7762.

CytoSorbents Quarterly Data

per share eps CPI Adj_EPS
201406 -0.270 100.560 -0.354
201409 -0.220 100.428 -0.289
201412 -0.450 99.070 -0.599
201503 -0.190 99.621 -0.251
201506 0.050 100.684 0.065
201509 -0.110 100.392 -0.144
201512 -0.130 99.792 -0.172
201603 -0.070 100.470 -0.092
201606 -0.120 101.688 -0.156
201609 -0.090 101.861 -0.116
201612 -0.190 101.863 -0.246
201703 -0.060 102.862 -0.077
201706 -0.060 103.349 -0.077
201709 -0.070 104.136 -0.089
201712 -0.110 104.011 -0.139
201803 -0.100 105.290 -0.125
201806 -0.190 106.317 -0.235
201809 -0.100 106.507 -0.124
201812 -0.170 105.998 -0.211
201903 -0.150 107.251 -0.184
201906 -0.110 108.070 -0.134
201909 -0.210 108.329 -0.255
201912 -0.120 108.420 -0.146
202003 -0.100 108.902 -0.121
202006 -0.080 108.767 -0.097
202009 -0.020 109.815 -0.024
202012 -0.010 109.897 -0.012
202103 -0.100 111.754 -0.118
202106 -0.110 114.631 -0.126
202109 -0.150 115.734 -0.171
202112 -0.210 117.630 -0.235
202203 -0.210 121.301 -0.228
202206 -0.250 125.017 -0.264
202209 -0.280 125.227 -0.295
202212 -0.010 125.222 -0.011
202303 -0.170 127.348 -0.176
202306 -0.140 128.729 -0.143
202309 -0.210 129.860 -0.213
202312 -0.120 129.419 -0.122
202403 -0.120 131.776 -0.120

Add all the adjusted EPS together and divide 10 will get our e10.


CytoSorbents  (NAS:CTSO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


CytoSorbents E10 Related Terms

Thank you for viewing the detailed overview of CytoSorbents's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


CytoSorbents (CytoSorbents) Business Description

Traded in Other Exchanges
Address
305 College Road East, Princeton, NJ, USA, 08540
CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.
Executives
Edward Raymond Jones director 70 HOGAN LANE, AMBLER PA 19002
Kathleen P. Bloch officer: Chief Financial Officer 3 PERSHING COURT, NORTH BRUNSWICK NJ 08902
Vincent Capponi officer: Chief Operating Officer MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Phillip P. Chan director, officer: President and CEO 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Efthymios Deliargyris officer: Chief Medical Officer C/O PLX PHARMA,INC.8285 EL RIO STREET, SUITE 210, HOUSTON TX 77054
Jiny Kim director C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Alan D. Sobel director 293 EISENHOWER PARKWAY, LIVINGSTON NJ 07039
Michael G. Bator director C/O CYTOSORBENTS CORP., 7 DEER PARK DR., SUITE K, MONMOUTH JUNCTION NJ 08852
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Al Kraus director MEDASORB TECHNOLOGIES, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Eric R. Mortensen officer: Chief Medical Officer C/O CYTOSORBENTS CORPORATION, 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852
Njtc Investment Fund, Lp 10 percent owner 1001 BRIGGS ROAD, SUITE 280, MOUNT LAUREL NJ 08054
Robert Shipley 10 percent owner 9 NOBLE ROAD, NOGALES AZ 85621
Ronald Berger officer: See Remarks 7 DEERPARK DRIVE, STE K, MONMOUTH JUNCTION NJ 08852
Thomas Bocchino officer: Chief Financial Officer C/O CYTOSORBENTS CORP., 7 DEER PARK DRIVE, SUITE K, MONMOUTH JUNCTION NJ 08852